Research Study

A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis
Principal Investigator 
Mark FitzGerald

Overview

Body Locations and Systems 
Lungs
ClinicalTrials.gov# 
NCT04442269
Status 
Recruiting
Study Start/End 
Nov 1, 2020
Locations 
Vancouver General Hospital
Name/Title 
Linda Hui
Phone 
604-875-5697
Email Address 
linda.hui@ubc.ca
Purpose of Study 

The purpose of this study is to determine if dupilumab is effective and safe in decreasing episodes of severe breathing difficulties in patients with allergic bronchopulmonary aspergillosis (ABPA).

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.